FMT
TXG icon

First Mercantile Trust’s 10x Genomics TXG Stock Holding History

First Mercantile Trust’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$737K Sell
5,063
-356
-7% -$61.1K 0.1% 128
2021
Q2 		$1.06M Buy
5,419
+383
+8% +$69.3K 0.13% 94
2021
Q1 		$912K Buy
+5,036
New +$870K 0.1% 111

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Mercantile Trust's TXG Position: Q3 2021 in Review

First Mercantile Trust reduced its 10x Genomics (TXG) stake by 6.6% in Q3 2021, selling an estimated $61.1K and leaving 5,063 shares worth $737K. The position accounts for 0.1% of the portfolio, ranked #128.

First Mercantile Trust first reported a position in TXG in Q1 2021 and has held it in 3 quarters since. The position peaked at $1.06M in Q2 2021. 330 funds tracked by Wall St. Rank hold TXG as of Q3 2021.

  • First Mercantile Trust held 5,063 shares of 10x Genomics worth $737K as of Q3 2021.
  • First Mercantile Trust sold 356 10x Genomics shares in Q3 2021, an estimated $61.1K.
  • 10x Genomics made up 0.1% of First Mercantile Trust's portfolio in Q3 2021, its #128 holding.
  • First Mercantile Trust first reported a position in 10x Genomics in Q1 2021 and has held it in 3 quarters since.
  • First Mercantile Trust's 10x Genomics position peaked at $1.06M in Q2 2021.
  • 330 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.